AARD · Aardvark Therapeutics, Inc. · Documents
Market Cap
$96.73M
Shares
21.88M
Volume · Oct 21
218.45K
Avg daily vol (3M)
130.57K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-10-08 | 2026-10-06 | |
| 8-K | — | 2026-08-17 | 2026-08-14 | |
| 8-K | — | 2026-08-11 | — | |
| 10-Q | — | 2026-08-11 | 2026-06-30 | |
| ARS | — | 2026-07-10 | 2025-12-31 | |
| DEF 14A | — | 2026-07-10 | 2026-08-14 | |
| PRE 14A | — | 2026-06-29 | 2026-08-14 | |
| 8-K | — | 2026-06-12 | 2026-06-10 | |
| 8-K | — | 2026-05-14 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| 8-K | — | 2026-05-07 | — | |
| 8-K | — | 2026-03-24 | 2026-03-23 | |
| 8-K | — | 2026-03-23 | — | |
| S-3 | — | 2026-03-23 | — | |
| 10-K | — | 2026-03-23 | 2025-12-31 | |
| 8-K | — | 2026-02-27 | — | |
| 8-K | — | 2026-02-12 | 2026-02-09 | |
| 8-K | — | 2026-02-10 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-12-10 | — | |
| 10-Q | — | 2025-11-13 | 2025-09-30 | |
| 8-K | — | 2025-11-13 | — | |
| 8-K | — | 2025-11-06 | 2025-11-05 | |
| 8-K | — | 2025-11-04 | — | |
| 8-K | — | 2025-10-09 | 2025-10-08 | |
| 8-K | — | 2025-09-03 | 2025-09-02 | |
| 8-K | — | 2025-08-13 | — | |
| 10-Q | — | 2025-08-13 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | — | |
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| 8-K | — | 2025-05-14 | — | |
| 8-K | — | 2025-03-31 | — | |
| 10-K | — | 2025-03-31 | 2024-12-31 | |
| 8-K | — | 2025-02-14 | — | |
| S-1/A | — | 2025-02-06 | — | |
| S-1 | — | 2025-01-23 | — |
Showing 1–36 of 36 filings